Early Detection of Treatment Response to Mavacamten in Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Regurgitation Using Magnetocardiography
ABSTRACT Recent evidence highlights the efficacy of mavacamten in reducing left ventricular outflow tract (LVOT) gradients in patients with hypertrophic cardiomyopathy (HCM), which is illustrated in this case. Additionally, the potential of magnetocardiography (MCG) as a novel, objective diagnostic...
Saved in:
| Main Authors: | Phillip Suwalski, Gamze Satilmis, Markus Reinthaler, Ulf Landmesser, Bettina Heidecker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.70667 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longitudinal assessment of systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy
by: Joonbum Seo, et al.
Published: (2024-11-01) -
Comprehensive Review: Mavacamten and Aficamten in Hypertrophic Cardiomyopathy
by: Helin Savsin, et al.
Published: (2025-07-01) -
Safety and Efficacy of Mavacamten and Aficamten in Patients With Hypertrophic Cardiomyopathy
by: Bryton J. Davis, et al.
Published: (2025-03-01) -
Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology
by: Ewelina Młynarska, et al.
Published: (2024-11-01) -
Mavacamten maintenance dose determination: insights into individualised therapy for hypertrophic cardiomyopathy
by: Kawa Mohemed, et al.
Published: (2025-03-01)